| 000 | 01624 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516004632.0 | ||
| 264 | 0 | _c20110504 | |
| 008 | 201105s 0 0 ger d | ||
| 022 | _a1432-1289 | ||
| 024 | 7 |
_a10.1007/s00108-010-2672-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWendtner, C-M | |
| 245 | 0 | 0 |
_a[Multimodality therapy concepts for soft tissue sarcomas]. _h[electronic resource] |
| 260 |
_bDer Internist _cNov 2010 |
||
| 300 |
_a1388-96 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aBenzamides |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 |
_aGastrointestinal Stromal Tumors _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHyperthermia, Induced |
| 650 | 0 | 4 | _aImatinib Mesylate |
| 650 | 0 | 4 |
_aIndoles _xadministration & dosage |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 | _aPalliative Care |
| 650 | 0 | 4 |
_aPiperazines _xadministration & dosage |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xadministration & dosage |
| 650 | 0 | 4 |
_aPyrimidines _xadministration & dosage |
| 650 | 0 | 4 |
_aPyrroles _xadministration & dosage |
| 650 | 0 | 4 | _aRadiotherapy, Adjuvant |
| 650 | 0 | 4 |
_aSarcoma _xepidemiology |
| 650 | 0 | 4 |
_aSoft Tissue Neoplasms _xepidemiology |
| 650 | 0 | 4 | _aSunitinib |
| 700 | 1 | _aDelank, S | |
| 700 | 1 | _aEich, H | |
| 773 | 0 |
_tDer Internist _gvol. 51 _gno. 11 _gp. 1388-96 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00108-010-2672-8 _zAvailable from publisher's website |
| 999 |
_c20242543 _d20242543 |
||